Your browser doesn't support javascript.
loading
Nitazoxanide impairs mitophagy flux through ROS-mediated mitophagy initiation and lysosomal dysfunction in bladder cancer.
Sun, Haiyan; Ou, Tong; Hu, Jianyang; Yang, Ziyi; Lei, Qifang; Li, Yuqing; Wang, Gang; Li, Yongpeng; Wu, Kai; Wang, Shupeng; Wu, Song.
Afiliación
  • Sun H; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Ou T; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China; Medical Laboratory, The Third Affiliated Hospital of Shenzhen University (
  • Hu J; Department of Biomedical Sciences, City University of Hong Kong, Hong Kong 999077, China.
  • Yang Z; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Lei Q; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Li Y; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Wang G; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Li Y; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Wu K; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Wang S; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China.
  • Wu S; Institute of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen 518000, China; Shenzhen Following Precision Medical Research Institute, Luohu Hospital Group, Shenzhen 518000, China; Teaching Center of Shenzhen Luohu Hospital, Shantou University Medical Col
Biochem Pharmacol ; 190: 114588, 2021 08.
Article en En | MEDLINE | ID: mdl-33957094
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_bladder_cancer Asunto principal: Tiazoles / Neoplasias de la Vejiga Urinaria / Especies Reactivas de Oxígeno / Mitofagia / Lisosomas / Antineoplásicos / Nitrocompuestos Límite: Animals / Female / Humans Idioma: En Revista: Biochem Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_bladder_cancer Asunto principal: Tiazoles / Neoplasias de la Vejiga Urinaria / Especies Reactivas de Oxígeno / Mitofagia / Lisosomas / Antineoplásicos / Nitrocompuestos Límite: Animals / Female / Humans Idioma: En Revista: Biochem Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: China